Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
287 participants
OBSERVATIONAL
2015-09-30
2020-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Peri-implant Conditions of Orthodontic Mini Implants
NCT06491849
Changes in Microbial Status From Dentate, Edentulous and After Dental Implant Placement
NCT06149585
A Randomized Controlled Clinical Trial to Assess Crestal Bone Remodeling of Four Different Implant Designs
NCT06821308
Evaluation of Implants Placed Immediately or Delayed Into Extraction Sites
NCT00067392
Frequency of Denture Cleanser Use and Denture Cleanliness
NCT02780661
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Teen
\< 17 years of age
Invisalign
Adult
17 years of age or older
Invisalign
Adult with Primer Aligners
17 years of age or older This group will get Primer Aligners
Invisalign
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Invisalign
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* For Teen treatment group, subjects ages \<17 years of age
* For Adult treatment group, subjects ≥17 years of age
Exclusion Criteria
* Subject with active caries
* Subject with periodontal disease
* Subject with TMD symptoms
* Subject has known allergy to latex or plastic
* Subjects who are pregnant or will become pregnant during treatment
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Align Technology, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr. Thomas Marcel
Livermore, California, United States
Dr. Mary Cooke
Napa, California, United States
Dr. Bella Shen Garnett
San Francisco, California, United States
Align Technology, Inc.
San Jose, California, United States
Dr. Robery Van den Berg
San Ramon, California, United States
Dr. Anil Idiculla
Lone Tree, Colorado, United States
Dr. Ryan Caudill
Merritt Island, Florida, United States
Dr. Sean Holliday
Pearl City, Hawaii, United States
Dr. Jeff Mastroianni
Glen Carbon, Illinois, United States
Dr. Mark Perelmuter
Louisville, Kentucky, United States
Dr. James Crouse
Salisbury, Maryland, United States
Dr. Zvi Kennet
Macomb, Michigan, United States
Dr. Thomas Everett
Burnsville, Minnesota, United States
Dr. Justin Wild
Eden Prairie, Minnesota, United States
Dr. Regina Blevins
Inver Grove Heights, Minnesota, United States
Dr. William Kottemann
Maple Grove, Minnesota, United States
Dr. Vincent D'Ascoli
Carson City, Nevada, United States
Dr. David Chenin
Henderson, Nevada, United States
Dr. Carlyn Phucas
Marlton, New Jersey, United States
Dr. David Paquette
Mooresville, North Carolina, United States
Dr. William Gierie
Wilmington, North Carolina, United States
Dr. Brian Amy
Oklahoma City, Oklahoma, United States
Dr. Clark Colville
Seguin, Texas, United States
Dr. Bart Iwasiuk
Brampton, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CSP-300313-00
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.